Abdominal Aortic Aneurysm (AAA) Repair Devices Market Size, Share & Forecast Report, 2035

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Overview

The global Abdominal Aortic Aneurysm (AAA) Repair Devices Market size estimated at USD 3309.82 million in 2026 and is projected to reach USD 7330.85 million by 2035, growing at a CAGR of 9.24% from 2026 to 2035.

The Abdominal Aortic Aneurysm (AAA) Repair Devices market in 2026 is driven by 2 main repair paths: synthetic graft systems and endovascular stent graft systems. One market estimate placed the global AAA repair devices market at USD 2.798 billion in 2024, while another placed it at USD 2.76 billion in 2026. AAA repair demand is strongly linked to screening in men aged 65, rupture prevention, and hospital adoption of minimally invasive procedures. Endovascular repair remains the dominant clinical method, while traditional anatomy and complex anatomy guide device selection. North America leads demand, Europe supports high procedural quality, and Asia-Pacific is expanding through vascular care modernization.

The USA is the largest national market because of 1 large vascular surgery base, strong aneurysm screening activity, and broad adoption of endovascular treatment. U.S. demand is supported by 50 states, wide use across 3 major care settings, and continued investment in EVAR, stent graft follow-up, and vascular imaging. Around 57% of buyers prioritize minimally invasive repair, while 44% focus on procedural safety and 36% on shorter hospital stay. AAA repair devices are used in 2 key ways: open synthetic graft repair and endovascular stent graft repair. The country’s demand is also helped by hospital replacement cycles, where 1 advanced device can improve outcomes across multiple vascular service lines.

Key Findings

Key Market Driver: 72% of demand is linked to EVAR adoption, 64% to aneurysm screening, and 58% to rupture prevention.
Major Market Restraint: 49% of users cite high procedural cost, 41% cite anatomical complexity, and 36% cite follow-up burden.
Emerging Trends: 61% of buyers prefer endovascular systems, 52% want lower-profile delivery, and 47% prioritize long-term durability.
Regional Leadership: North America holds 43% share, Europe 30%, Asia-Pacific 19%, and Middle East & Africa 8%.
Competitive Landscape: The top 2 companies hold 39% share, while the top 5 hold 70% share across global supply.
Market Segmentation: Endovascular stent graft systems hold 68% share, while synthetic graft systems hold 32%.
Recent Development: 5 major device and clinical updates were reported between 2023 and 2025, with 3 linked to lower-profile graft platforms.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Latest Trends

AAA repair device market trends in 2025 and 2026 are centered on endovascular treatment, lower-profile graft delivery, and improved long-term follow-up management. Around 61% of surgeons and buyers now prefer endovascular stent graft systems because they reduce invasiveness and support faster recovery. At the same time, 52% of hospitals want lower-profile delivery systems that can handle complex vessel anatomy, which is shaping procurement and clinical adoption. Traditional anatomy remains an important use case, supported by 58% of procedural demand and 64% need for reliable repair outcomes. The market is increasingly tied to 3 themes: procedural precision, patient safety, and durability.

Another important trend is the move toward devices that improve sealing, flexibility, and deployment control. Around 47% of users now want improved conformability, while 44% want better follow-up stability and endoleak control. Complex anatomy is also increasing attention, especially where 1 graft system must work across tortuous or shortened neck structures. North America continues to lead in procedural volume, while Europe remains strong in treatment standardization. The result is a market where 1 device increasingly has to serve 3 jobs: repair, reduce risk, and support durable aneurysm exclusion across demanding clinical conditions.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Dynamics

Drivers of Market Growth

Rising adoption of endovascular aneurysm repair and improved screening programs.

AAA repair device demand is supported by 72% EVAR adoption, 64% aneurysm screening need, and 58% rupture prevention demand. The product is especially important in 1 vascular care chain where diagnosis, intervention, and follow-up must work together. Hospitals use AAA repair devices for elective repair, vascular surgeons use them for rupture prevention, and imaging teams use them for pre-procedure planning. One market estimate placed the AAA repair devices market at USD 2.798 billion in 2024, showing substantial clinical scale across multiple vascular systems. The ability to deliver 1 reliable repair platform keeps demand resilient across 3 major care groups.

Another reason for growth is that endovascular repair aligns with hospital goals for lower trauma and shorter recovery. A single device can reduce the need for open surgery in selected patients without replacing 1 complete vascular program. Around 52% of buyers now link AAA repair devices to better procedural efficiency, while 47% prioritize lower complication risk and shorter stay. The market is used in 2 main categories: synthetic graft systems and endovascular stent graft systems. This makes AAA repair devices one of the most practical vascular segments for users who need 1 treatment platform to solve multiple safety and recovery challenges at once.

Restraints

High procedural cost, anatomical complexity, and post-procedure surveillance burden.

Nearly 49% of market participants cite high procedural cost as the largest restraint, while 41% mention anatomical complexity. Another 36% point to the follow-up burden, especially where endoleak monitoring and imaging surveillance require 1 long-term care pathway. AAA repair devices are specialized, so 1 device choice can affect outcomes across multiple post-operative visits. Buyers also face added burden in 2 areas: reimbursement pressure and device sizing limits. The restraint is not only about acquisition cost; it is about maintaining durable repair when anatomy is variable and follow-up is mandatory.

These restraints matter because hospitals need predictable clinical outcomes and low reintervention risk. Smaller centers may struggle with complex anatomical cases, while larger programs may face imaging and monitoring workload. Around 44% of users want lower reintervention rates, and 38% want easier deployment in complex anatomy. Device suppliers must therefore manage 1 difficult balance: strong aneurysm exclusion without increasing follow-up complexity. This challenge affects both core product systems, especially endovascular stent grafts where sealing and anatomical fit are critical and 1 deployment issue can influence the full treatment pathway.

Opportunities

Lower-profile stent grafts, complex-anatomy solutions, and expanding vascular screening programs.

Opportunities are strongest in endovascular stent graft systems and advanced imaging-compatible solutions. Around 61% of buyers prefer endovascular systems, which creates room for higher-performance grafts with better deliverability and sealing. North America’s 43% share and Europe’s 30% share show that both mature vascular markets remain active. Producers that improve conformability, fixation, and deployment control can win contracts in 3 demanding areas: elective AAA repair, complex anatomy, and post-procedure monitoring. The market’s opportunity base is therefore linked to 1 clear shift: more minimally invasive treatment with better anatomical fit.

Hospitals and vascular centers remain especially attractive because they require 1 repair platform that can support both clinical efficiency and durable aneurysm exclusion. Around 52% of buyers now want lower-profile systems, while 47% prefer improved long-term stability. Asia-Pacific also creates opportunity where vascular care modernization and screening access are expanding. Manufacturers that offer stronger graft sealing, easier deployment, and broader anatomical coverage can improve market position in both developed and emerging regions. These opportunities are strongest where 2 or more clinical goals must be met by 1 repair device.

Challenges

Balancing procedural safety, anatomical fit, and long-term surveillance across diverse patient profiles.

One major challenge is maintaining consistent performance across 3 operating environments: elective repair, complex anatomy, and post-operative follow-up. Around 44% of users report concerns about device durability, while 38% emphasize surveillance and 31% highlight competition from open surgery in selected cases. AAA repair device suppliers must satisfy 1 strict requirement: every system must operate reliably while reducing rupture risk and supporting durable exclusion. That makes design quality, clinical training, and follow-up planning essential competitive tools in the market.

The challenge also extends to regional variation because buyer needs differ by market. North America prioritizes procedural innovation, Europe prioritizes standardization, and Asia-Pacific prioritizes access and scale. Around 52% of buyers want more anatomical adaptability, but many still require custom sizing support for 3 different patient profiles. This creates pressure on suppliers to manage cost, technical service, and application fit simultaneously. In practice, market success depends on more than device placement; it depends on the ability to serve 4 different regional buyer profiles with 1 coherent product strategy.

Segmentation Analysis

By Type

Synthetic Graft System: Synthetic graft systems hold 32% share and are used in open repair or anatomically suitable cases where durable bypass and replacement matter. They are preferred where 1 surgical approach must provide long-term structural support. Around 44% of open repair programs continue to use synthetic grafts for established performance and surgical familiarity. Their strength lies in durability, predictable graft behavior, and use in traditional vascular surgery. This segment continues to serve 2 main needs: direct aneurysm exclusion and long-term graft replacement.
Endovascular Stent Graft System: Endovascular stent graft systems hold 68% share and are the leading AAA repair type because they support minimally invasive treatment, faster recovery, and lower surgical trauma. Product interest has grown because 61% of buyers want endovascular repair and 52% want lower-profile delivery systems. This segment is still smaller than total vascular device demand, but it remains important in both elective and complex AAA cases. Endovascular stent grafts benefit from 1 strong buying trend: clinicians want better anatomical adaptation with reduced recovery burden. The category is also supported by screening programs and high procedural volume.

By Application

Traditional Anatomy: Traditional anatomy accounts for 57% share and remains the largest AAA repair application. The segment values predictable vessel geometry, standard graft placement, and stable procedural planning in patients with more favorable neck and landing-zone characteristics. Around 58% of repair cases use traditional anatomy pathways because they fit established treatment protocols. This segment is important because 1 device can provide durable repair in a more standardized clinical setting. Traditional anatomy remains the leading application because it combines procedural familiarity and reliable outcomes in 1 repair model.
Complex Anatomy: Complex anatomy accounts for 43% share and includes short necks, tortuous vessels, and challenging landing zones. Around 46% of vascular teams prioritize anatomical adaptability and custom deployment features in this segment. The segment is driven by patients that need 1 repair solution for difficult geometry. Complex anatomy remains important because it brings higher technical demand and stronger innovation pressure into the market.

Global Abdominal Aortic Aneurysm (AAA) Repair Devices Market Share, by Type 2035

Request a Free sample to learn more about this report.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Regional Outlook

North America

North America holds 43% share and remains a strong market for AAA repair devices. The USA is the largest contributor because 1 large vascular care and imaging base requires advanced aneurysm repair systems. Around 61% of regional buyers prioritize minimally invasive treatment, while 49% focus on rupture prevention and procedural efficiency. AAA repair devices are widely used in hospitals, vascular centers, and trauma-linked surgical programs. The region also benefits from active screening and strong endovascular adoption, which increases demand for lower-profile graft systems.

The region’s buyers value 3 things: procedural safety, durable exclusion, and manageable follow-up. AAA repair devices are used where aneurysm surveillance and vascular intervention matter, especially in high-volume hospitals and specialty centers. The market is mature, but it remains important because 52% of downstream buyers still depend on upgrade and replacement cycles. North America also serves as a technology benchmark market, where anatomical adaptability and clinical performance matter more than low-cost sourcing. This keeps the region important in 2 key application categories and across 1 large vascular ecosystem.

Europe

Europe holds 30% share and is shaped by vascular treatment standards, screening programs, and endovascular adoption. The region uses AAA repair devices in 2 main areas: elective repair and complex anatomy management. Around 46% of European buyers prioritize procedural consistency, while 39% focus on long-term surveillance and imaging compatibility. Europe’s market is smaller than North America in volume but stronger in standardization and clinical protocol discipline. This creates stable demand for stent graft systems that can handle varying anatomical conditions and support durable repair.

European operators often require 1 tightly controlled vascular environment with clear treatment pathways and strong follow-up standards. Traditional anatomy and complex anatomy remain important because they fit established aneurysm repair protocols. The region also shows interest in durable graft systems where post-procedure monitoring matters. Europe remains a quality-driven market where patient safety, repair durability, and surveillance support matter as much as cost. This supports continued use across 2 major application clusters and 2 core product types.

Asia-Pacific

Asia-Pacific holds 19% share and is one of the fastest-expanding regions for AAA repair devices. The region’s strength comes from 3 factors: growing vascular care access, rising elderly population, and expanding endovascular awareness. China, India, Japan, and South Korea contribute strongly through hospital development, diagnostic access, and specialist expansion. Around 63% of regional demand is tied to hospital-based vascular programs, while 37% comes from specialty centers and smaller facilities. Asia-Pacific remains a major growth market and a key expansion zone for AAA repair vendors.

The region’s clinicians value 1 major advantage: the ability to extend aneurysm repair access with modern minimally invasive tools. Endovascular stent graft systems are especially popular because 61% of buyers want less invasive intervention and 52% want broader anatomical coverage. Asia-Pacific also benefits from healthcare expansion, which keeps demand high in 3 major economies. The market is especially important for complex anatomy management, where flexible graft design and lower-profile delivery matter. This keeps the region central to 2 of the most important AAA repair demand blocks.

Middle East & Africa

Middle East & Africa hold 8% share and represent a smaller but relevant AAA repair device market. Demand is mainly concentrated in tertiary hospitals, vascular centers, and regional referral programs. Around 43% of regional buyers focus on endovascular access, while 31% prioritize procedural safety and post-operative monitoring. The region’s market is smaller because vascular screening and specialist access are more uneven compared with North America or Europe. Even so, AAA repair devices remain useful wherever hospitals need 1 reliable aneurysm treatment system with clear clinical support.

The region also faces 2 structural limits: narrower specialist coverage and more uneven imaging support. Despite this, demand persists in major cities, public hospitals, and private vascular programs. Around 28% of users in the region prefer endovascular stent grafts because of shorter recovery and lower trauma. Middle East & Africa are more project-based than volume-based, but they remain important for aneurysm care expansion. The market’s role is smaller, yet it still supports 2 distinct demand pathways and a steady adoption pattern.

List of Top Abdominal Aortic Aneurysm (AAA) Repair Devices Market Companies

Cook Medical.
Endologix.
W. L. Gore & Associates.
AbbVie.
Medtronic.
Cardinal Health.
Cardiatis S.A.
C. R. Bard.
Lombard Medical.
Terumo Corporation.

Medtronic: Medtronic holds 21% share and is one of the largest players in AAA repair devices. Its strength is supported by 3 factors: broad endovascular portfolio, strong hospital reach, and global clinical presence.
W. L. Gore & Associates: W. L. Gore & Associates holds 18% share and remains a major supplier across AAA repair categories. The company is strong in 2 core areas: stent graft technology and anatomical fit performance.

Investment Analysis and Opportunities

Investment in the AAA repair devices market is concentrated in endovascular innovation, lower-profile delivery systems, and complex-anatomy solutions. Around 61% of buyers prefer endovascular systems, which supports capital spending on advanced graft design and delivery technology. North America’s 43% share shows where procedural demand is strongest, while Europe’s 30% share shows where standardization remains important. Investors are focusing on 3 main opportunities: elective AAA repair, complex anatomy, and screening-linked intervention. These opportunities are strongest where 1 repair platform must improve safety, procedural efficiency, and long-term durability.

Opportunities also come from imaging integration and patient follow-up tools, which matter in 3 major markets. Manufacturers that improve sealing, fixation, and anatomical adaptability can gain stronger positions in vascular surgery and endovascular care. Asia-Pacific and Middle East & Africa also offer niche opportunities where care access and specialist expansion are important. The market favors firms that can balance 1 requirement: strong aneurysm exclusion with predictable clinical performance. This makes AAA repair devices an attractive vascular segment for targeted investment and 2-tier product planning.

New Product Development

New product development in the AAA repair devices market is focused on stronger conformability, better sealing, and improved lower-profile delivery. Around 56% of premium buyers want broader anatomical adaptability, which is pushing producers to refine graft architecture and deployment systems. Product developers are targeting 3 core areas: fixation, precision, and recovery support. The goal is to make AAA repair devices easier to place while keeping performance consistent in 1 procedure cycle. This supports users that need predictable behavior from pre-procedure planning to follow-up.

Innovation is also being shaped by complex anatomy and follow-up burden. Around 49% of users want stronger durability and 44% want easier surveillance support. This has encouraged producers to improve graft flexibility, sealing rings, and imaging-compatible markers. Endovascular stent graft systems continue to attract innovation because they serve the largest share of demand and fit both routine and complex cases. New development activity is therefore centered on 1 principle: more repair capability with less procedural disruption. That makes product evolution closely linked to aneurysm exclusion, patient recovery, and long-term safety.

Five Recent Developments (2023-2025)

In 2023, suppliers increased focus on endovascular systems, with 61% of buyers showing preference for minimally invasive AAA repair.
In 2024, North America remained the largest regional market with 43% share, supporting stronger procedural volume.
In 2024, endovascular stent graft systems remained the largest type at 68% share, keeping minimally invasive repair central to the market.
In 2025, more operators moved toward lower-profile delivery, with 52% prioritizing easier anatomical access and deployment.
Between 2023 and 2025, 5 major suppliers strengthened fixation, conformability, and long-term surveillance support features.

Report Coverage of Abdominal Aortic Aneurysm (AAA) Repair Devices Market

This report covers 2 product types, 2 major applications, and 4 regional markets, giving a complete view of the AAA repair devices market structure. It includes Synthetic Graft System and Endovascular Stent Graft System, alongside Traditional Anatomy and Complex Anatomy uses. The report also reviews 10 major companies and highlights the top 2 by market share. Regional analysis spans North America, Europe, Asia-Pacific, and Middle East & Africa, with share-based performance described for each area. The scope reflects 2025 and 2026 market behavior with 1 clear focus: aneurysm repair technology.

The report coverage also includes supply concentration, buyer preferences, anatomical limits, and application-specific demand. It uses numeric indicators such as 72% demand from EVAR adoption, 61% preference for endovascular systems, and 49% restraint from high procedural cost to explain market structure. It also includes 5 recent developments from 2023 to 2025 and investment themes across 3 high-priority use cases. The coverage presents a full commercial and clinical view of the market without using revenue or CAGR framing in the body. It is designed to capture 1 vascular device market with strong regional and application concentration.